- /
- Supported exchanges
- / US
- / ACHV.NASDAQ
Achieve Life Sciences Inc (ACHV NASDAQ) stock market data APIs
Achieve Life Sciences Inc Financial Data Overview
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Achieve Life Sciences Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Achieve Life Sciences Inc data using free add-ons & libraries
Get Achieve Life Sciences Inc Fundamental Data
Achieve Life Sciences Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -54 652 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Achieve Life Sciences Inc Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2026-03-12
- EPS/Forecast: -0.2771
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Achieve Life Sciences Inc News
New
Achieve Life Sciences, Inc. Q4 2025 Earnings Call Summary
Achieve Life Sciences, Inc. Q4 2025 Earnings Call Summary - Moby Strategic Transformation and Operational Context Transitioned from a clinical development firm to a commercially focused enterprise f...
ACHV: 2025 Results
By John Vandermosten, CFA NASDAQ: ACHV READ THE FULL ACHV RESEARCH REPORT Achieve Life Sciences, Inc. (NASDAQ: ACHV) reported 2025 results following the submission of a new drug application (NDA) t...
Here are the major earnings before the open Tuesday
Major earnings expected before the bell on Tuesday include: * Xiaomi Corporation (XIACF [https://seekingalpha.com/symbol/XIACF]) * Vertical Aerospace Ltd. (EVTL [https://seekingalpha.com/symbol/E...
Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory
We came across a bullish thesis on Achieve Life Sciences, Inc. on Hunterbrook’s Substack. In this article, we will summarize the bulls’ thesis on ACHV. Achieve Life Sciences, Inc.'s share was tra...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.